Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Novartis forms digital health investment company with Qualcomm

Expands work with Tricorder prize firm to develop 'beyond-the-pill' initiatives

Sanofi reception

Monthly dosing effective for Sanofi’s alirocumab

New data puts pressure on Amgen's evolocumab

- PMLiVE

AZ signs yet another cancer immunotherapy deal

Will work with Omnis to develop viruses that target tumour cells

- PMLiVE

EC gives nod to restless leg syndrome drug Targin

Mundipharma’s medicine is first opioid granted a licence for condition in the EU

Shire Basingstoke

Shire signs deal to buy NPS for $5.2bn

Firm hopes to boost its presence in rare disease sector

- PMLiVE

COUCH names Jenny McParland as account executive

She is a recent neuroscience graduate

- PMLiVE

Evan Lippman joins Aileron Therapeutics

He has experience at EMD Serono, Pfizer and AstraZeneca

Cubist: Meeting the challenge in antibiotics

Patrick Vink on Cubist Pharmaceuticals’ ambitions in anti-infectives, which have attracted the attention of Merck & Co

23andMe signs Parkinson’s deal with Genentech

Adds to list of pharma tie-ups for genetic testing firm

Digital diagnostic tech improves GP accuracy

New study says using digital diagnostic advice can help reduce risk of misdiagnosis

Daiichi Sankyo logo

Daiichi’s novel anticoagulant Savaysa cleared in US

Approval comes more than three years after it was approved in Japan

- PMLiVE

Gates Foundation sponsors arts campaign to promote vaccination

Social media will play a role in raising awareness for the project

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links